title: Antibody-mediated rejection: analyzing the risk, proposing solutions.
authors.affiliation: 1 Nephrology Department, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain. 2 Instituto Carlos III, Red de Investigació en Enfermedades Renales (REDinREN), Madrid, Spain. 3 Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 4 Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada. 5 Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada. 6 Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada. 7 Nephrology Department, Hospital Universitari Vall D ´Hebron, Barcelona, Spain. 8 Immunology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain. 9 Heart Transplant Program, Cardiology Department, Complejo Universitario de A Coruña, Spain. 10 Pneumology Department, Hospital Universitari Vall D ´Hebron, Barcelona, Spain. 11 Department of Nephrology, Hospital Universitari Vall D ´Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain. 12 Nephrology and Dialysis Division, Medical University Vienna, Austria. 13 Address correspondence to: Manuel Arias, M.D., Nephrology Department, Edificio 2 de Noviembre, planta 1a, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
authors.forename: Manuel
authors.initials: M
authors.lastname: Arias
authors.forename: David N
authors.initials: DN
authors.lastname: Rush
authors.forename: Chris
authors.initials: C
authors.lastname: Wiebe
authors.forename: Ian W
authors.initials: IW
authors.lastname: Gibson
authors.forename: Tom D
authors.initials: TD
authors.lastname: Blydt-Hansen
authors.forename: Peter W
authors.initials: PW
authors.lastname: Nickerson
authors.forename: Joana
authors.initials: J
authors.lastname: Sellarés
authors.forename: Marcos
authors.initials: M
authors.lastname: López-Hoyos
authors.forename: David
authors.initials: D
authors.lastname: San Segundo
authors.forename: María G
authors.initials: MG
authors.lastname: Crespo-Leiro
authors.forename: Raquel
authors.initials: R
authors.lastname: Marzoa-Rivas
authors.forename: Eduardo
authors.initials: E
authors.lastname: Barge-Caballero
authors.forename: María J
authors.initials: MJ
authors.lastname: Paniagua-Martín
authors.forename: Antonio
authors.initials: A
authors.lastname: Román
authors.forename: Daniel
authors.initials: D
authors.lastname: Serón
authors.forename: Georg
authors.initials: G
authors.lastname: Böhmig
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Schwaiger
mesh_terms: D000906:Antibodies / Q000276:immunology*; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D056724:Immunity, Humoral; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D012306:Risk; D014180:Transplantation / Q000379:methods*
chemical_list: D000906:Antibodies; D006680:HLA Antigens; D007166:Immunosuppressive Agents